Document is current

Article History

Accepted: 28 September 2023

First Online: 2 December 2023

Declarations

:

: This research was funded by a University of Galway Hardiman Scholarship and the Irish Research Council under grant number GOIPG/2021/107. The funders had no role in the study design, the collection, analysis or interpretation of data, in the writing of this report or in the decision to submit it for publication. This report represents the consensus opinion of the task force membership and does not necessarily reflect the views of the institutions to which they are affiliated.

: Edward Henry reports receiving an Irish Research Council grant (GOIPG/2021/107) and a University of Galway Hardiman Scholarship that has funded this and other aspects of his PhD programme of study, and receiving funding from the EuroQol Group to cover travel and accommodation to attend a EuroQol Academy Meeting and speak about this project. Hareth Al-Janabi reports consulting fees in the last 36 months relating to advice on the methods for economic evaluations and carer quality-of-life measurement from Curta, Ferring, PHMR and Roche. Werner Brouwer reports previous funding from the European Union, ZonMW and pharmaceutical companies to the Erasmus University Rotterdam in relation to spillover work. Andrew Lloyd reports receiving support from the EuroQol Group for travel costs to discuss aspects of this work at a meeting in Milan, Italy (2023). Nalin Payakachat is a full-time employee at Eli Lilly and Company. However, this work is her individual contribution. Eli Lily and Company has no financial interest in subject matter discussed in this manuscript. Becky Pennington reports receiving funding from the National Institute for Health Research (300160) and consulting fees from Roche/Genentech, Takeda and the Office for Health Economics for work related to carers’ health-related quality of life, and received funding to cover travel expenses and accommodation from the EuroQol Group at a plenary meeting. Becky Pennington is a member of National Institute for Health and Care Excellence (NICE) Technology Appraisal Committee A. This work does not represent the views of any of these funders or organisations. Koonal Shah is employed by NICE. The views expressed in this article do not necessarily reflect the views of NICE. John Cullinan, Lidia Engel, Susan Griffin, Claire Hulme, Pritaporn Kingkaew, Luz María Peña-Longobardo, Lisa A. Prosser, Wendy J. Ungar, Thomas Wilkinson and Eve Wittenberg have no conflicts of interest that are directly relevant to the content of this article.

: Not applicable.

: Not applicable.

: All data pertaining to this study are available from the corresponding authors upon reasonable request.

: Not applicable.

: EH, HA, JC and EW contributed to the conception and design of the work. All authors engaged in the preparation and conduct of the modified nominal group technique. EH performed the data analysis and drafted the initial report. All authors reviewed the manuscript critically for important intellectual content and approved the final version.

: All authors give consent for publication.